IP Verse

Laboratorios Hipra competitive analysis

Loading summary...

Explore patent oppositions filed by Laboratorios Hipra against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP2275132	Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Them	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Mar 4, 2021
EP3320919	Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Feb 24, 2021
EP3127551	Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In Pigs	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Sep 15, 2020
EP3076996	Vaccine Against Porcine Circo Virus Type 2	INTERVET	Jul 10, 2020
EP2460820	Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Jan 8, 2020
EP2481420	Single Dose Anti-Pcv2 Pig Vaccine	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Nov 20, 2019
EP1968630	Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions	BOEHRINGER INGELHEIM ANIMAL HEALTH USA	Oct 24, 2018

Explore the latest publications and patents granted to Laboratorios Hipra, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Laboratorios Hipra, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Laboratorios Hipra with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
LABORATORIOS HIPRA	7	-	-	-
BOEHRINGER INGELHEIM ANIMAL HEALTH USA	16	30	2	-
BOEHRINGER INGELHEIM VETMEDICA	18	29	-	4
INTERVET	11	34	4	1